Chargement…
Médicaments publiés par l'ARP : médicament, DCI, dosage, forme galénique, voie d'administration, laboratoire et classe thérapeutique.
7 458 enregistrements · affichage 4 951–4 975
| NOM DU MEDICAMENT | DCI | dosage | présentation | Forme Galénique | Voie d'administration | Laboratoire | classe thérapeutique |
|---|
3a3a5d10b20f…Empreinte d'intégrité du fichier source, publique et sans valeur de secret.| EFFEXOR LP | VENLAFAXINE | 75 mg | B/30 | gélule | orale | PFIZER HOLDING FRANCE | ANXIOLYTIQUE |
| EFFERCAL | CALCIUM/CHOLECALCIFEROL | 200 UI / 250 mg | B/20 | comprimé effervescent | orale | ACTON PHARMA LIMITED | COMPLEMENT ALIMENTAIRE |
| EFFERALGAN VITAMINE C | ACIDE ASCORBIQUE/PARACETAMOL | 200 mg / 500 mg | B/16 | comprimé effervescent | orale | BRISTOL MYERS SQUIBB | ANTALGIQUE / ANTIASTHENIQUE |
| EFFERALGAN PLUS | Paracetamol+cafeine | 500mg+65mg | COMPRIME | orale | UPSA | ||
| EFFERALGAN CODEINE | PARACETAMOL/CODEINE | 500 mg /30 mg | B/16 | comprimé effervescent | orale | UPSA | |
| EFFERALGAN CODEINE | PARACETAMOL/CODEINE | 500 mg / 30 mg | B/16 | comprimé | orale | UPSA | |
| EFFERALGAN | PARACETAMOL | 150 mg | B/10 | suppositoire | rectale | UPSA | |
| EFFERALGAN | PARACETAMOL | 250 mg | B/12 | sachet | orale | UPSA | |
| EFFERALGAN | PARACETAMOL | 30 mg/ml | FL/90 ml | suspension buvable | orale | UPSA | |
| EFFERALGAN | PARACETAMOL | 3% | F/90 ml | solution buvable | orale | UPSA | |
| EFFERALGAN | PARACETAMOL | 1 g | B/8 | comprimé effervescent | orale | BRISTOL MYERS SQUIBB | ANTALGIQUE |
| EFFERALGAN | PARACETAMOL | 80 mg | B/10 | suppositoire | rectale | UPSA | |
| EFFERALGAN | PARACETAMOL | 1000 mg | B/8 | comprimé pelliculé | orale | BRISTOL MYERS SQUIBB | ANTALGIQUE |
| EFFERALGAN | PARACETAMOL | 150 mg | B/12 | sachet | orale | UPSA | ANTALGIQUE |
| EFFERALGAN | PARACETAMOL | 500 mg | B/16 | capsule | orale | UPSA | |
| EFFERALGAN | PARACETAMOL | 500 mg | B/16 | comprimé effervescent | orale | UPSA | ANTALGIQUE |
| EFFEDERM | TRETINOINE | 50 mg | T/30 g | crème dermique | cutanée | C.S DERMATOLOGIE | ANTIACNEÏQUE |
| EFFALPHA | ACIDE GLYCOLIQUE/BIPODMINOSCIDES D’ORIGINE VEGETALE/EAU THERMALE DE LA ROCHE POSAY/PIDOLATE DE ZINC | T/40 ml | crème dermique | cutanée | ROCHE POSAY | ANTISEPTIQUE | |
| EFFACLAR | CYSTEATE DE ZINC | 0% | T/125 ml | solution à usage externe | cutanée | ROCHE POSAY | ANTIACNEÏQUE |
| EFCURE | EFAVIRENZ | 200 mg | B/30 | comprimé | orale | EMCURE PHARMACEUTICALS LTD | ANTIRETROVIRAL |
| EFCURE | EFAVIRENZ | 200 mg | B/30 | comprimé | orale | EMCURE PHARMACEUTICALS LTD | ANTIRETROVIRAL |
| EFAVIRENZ/EMTRICITABINE/TENOFOVIR HETERO | EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 200 mg / 300 mg / 600 mg | B/30 | comprimé | orale | HETERO LABS LIMITED | ANTIRETROVIRAL |
| EFAVIRENZ, EMTRICITABINE ET FUMARATE DE TENOFOVIR | EFAVIRENZ, EMTRICITABINE ET FUMARATE DE TENOFOVIR | 600 mg / 200 mg / 300 mg | B/30 | comprimé | orale | HETERO LABS LIMITED | |
| EFAVIRENZ MATRIX | EFAVIRENZ | 600 mg | B/30 | comprimé | orale | MATRIX LABORATORIES LIMITED | ANTIRETROVIRAL |
| EFAVIRENZ MACLEODS | EFAVIRENZ | 600 mg | B/30 | comprimé | orale | MACLEODS | ANTIRETROVIRAL |
EFFEXOR LP
EFFERCAL
EFFERALGAN VITAMINE C
EFFERALGAN PLUS
EFFERALGAN CODEINE
EFFERALGAN CODEINE
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFERALGAN
EFFEDERM
EFFALPHA
EFFACLAR
EFCURE
EFCURE
EFAVIRENZ/EMTRICITABINE/TENOFOVIR HETERO
EFAVIRENZ, EMTRICITABINE ET FUMARATE DE TENOFOVIR
EFAVIRENZ MATRIX
EFAVIRENZ MACLEODS